PT96639A - Processo para a preparacao de uma composicao propulsora contendo hidro-fluoro-carbonetos - Google Patents

Processo para a preparacao de uma composicao propulsora contendo hidro-fluoro-carbonetos

Info

Publication number
PT96639A
PT96639A PT96639A PT9663991A PT96639A PT 96639 A PT96639 A PT 96639A PT 96639 A PT96639 A PT 96639A PT 9663991 A PT9663991 A PT 9663991A PT 96639 A PT96639 A PT 96639A
Authority
PT
Portugal
Prior art keywords
preparation
composition containing
propellant composition
fluorohydrocarbons
propellant
Prior art date
Application number
PT96639A
Other languages
English (en)
Other versions
PT96639B (pt
Inventor
Gerald Staele
Joseph Geok Paan Lim
Asit Somani
Original Assignee
Fisons Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB909002351A external-priority patent/GB9002351D0/en
Priority claimed from GB909023655A external-priority patent/GB9023655D0/en
Priority claimed from GB909026476A external-priority patent/GB9026476D0/en
Application filed by Fisons Plc filed Critical Fisons Plc
Publication of PT96639A publication Critical patent/PT96639A/pt
Publication of PT96639B publication Critical patent/PT96639B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Colloid Chemistry (AREA)
PT96639A 1990-02-02 1991-02-01 Processo para a preparacao de uma composicao propulsora contendo hidro-fluoro-carbonetos PT96639B (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB909002351A GB9002351D0 (en) 1990-02-02 1990-02-02 Pharmaceutical compositions
GB909023655A GB9023655D0 (en) 1990-10-31 1990-10-31 Pharmaceutical compositions
GB909026476A GB9026476D0 (en) 1990-12-05 1990-12-05 Pharmaceutical compositions

Publications (2)

Publication Number Publication Date
PT96639A true PT96639A (pt) 1991-10-31
PT96639B PT96639B (pt) 1998-07-31

Family

ID=27264918

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96639A PT96639B (pt) 1990-02-02 1991-02-01 Processo para a preparacao de uma composicao propulsora contendo hidro-fluoro-carbonetos

Country Status (14)

Country Link
US (1) US6582677B1 (pt)
EP (1) EP0513127B1 (pt)
JP (1) JP2858948B2 (pt)
AT (1) ATE125153T1 (pt)
CA (1) CA2074495C (pt)
DE (1) DE69111426T2 (pt)
DK (1) DK0513127T3 (pt)
ES (1) ES2075956T3 (pt)
GR (1) GR3017611T3 (pt)
IE (1) IE67185B1 (pt)
IL (1) IL97065A (pt)
NZ (1) NZ236948A (pt)
PT (1) PT96639B (pt)
WO (1) WO1991011173A1 (pt)

Families Citing this family (105)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5766573A (en) 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
DE4003270A1 (de) 1990-02-03 1991-08-08 Boehringer Ingelheim Kg Neue treibgase und ihre verwendung in arzneimittelzubereitungen
EP0526481B1 (en) * 1990-03-23 1995-04-26 Minnesota Mining And Manufacturing Company The use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
WO1992000107A1 (en) * 1990-06-28 1992-01-09 Glaxo Inc. Aerosol drug formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
JP2769925B2 (ja) * 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
GB9024366D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
GB9103824D0 (en) * 1991-02-23 1991-04-10 Fisons Ag Formulation
DE69231994T3 (de) * 1991-06-10 2010-01-21 Schering Corp. Fluorchlorkohlenwasserstofffreie Aerosolformulierungen
ATE339952T1 (de) 1991-06-10 2006-10-15 Schering Corp Fluorchlorkohlenwasserstofffreie aerosolformulierungen
NZ244439A (en) 1991-09-25 1994-01-26 Fisons Plc Pressurised aerosol compositions comprising hydrofluoroalkane, dispersed
US6123924A (en) * 1991-09-25 2000-09-26 Fisons Plc Pressurized aerosol inhalation compositions
US5658549A (en) * 1991-12-12 1997-08-19 Glaxo Group Limited Aerosol formulations containing propellant 134a and fluticasone propionate
US5916540A (en) 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
US5744123A (en) * 1991-12-12 1998-04-28 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicaments
IL104068A (en) * 1991-12-12 1998-10-30 Glaxo Group Ltd Pharmaceutical preparations in a spray without surfactant containing 1, 1, 1, 2 tetrafluoroethane or 1,1,2,3,3 petafluor N propane as propellant
US5683676A (en) * 1991-12-12 1997-11-04 Glaxo Group Limited Canister containing aerosol formulations containing P134a and particulate medicaments
NZ246046A (en) * 1991-12-12 1995-12-21 Glaxo Group Ltd Aerosol comprising a particulate medicament in a fluorocarbon or chlorofluorohydrocarbon and a polar cosolvent
DK0616524T3 (da) 1991-12-12 1999-06-21 Glaxo Group Ltd Lægemidler
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
US5674471A (en) * 1991-12-12 1997-10-07 Glaxo Group Limited Aerosol formulations containing P134a and salbutamol
GB9202522D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
US5376359A (en) * 1992-07-07 1994-12-27 Glaxo, Inc. Method of stabilizing aerosol formulations
ES2064244B1 (es) * 1992-12-02 1995-09-01 Fisons Plc Composiciones de aerosol presurizadas.
ATE144151T1 (de) * 1993-01-19 1996-11-15 Hoechst Ag Flüssiggasformulierung zur vitalitätsprüfung von zähnen
FR2701859B1 (fr) * 1993-02-23 1995-04-28 Lenglen Jean Luc Procédé pour mélanger un gaz avec au moins un liquide.
DE4323636A1 (de) * 1993-07-15 1995-01-19 Hoechst Ag Arzneistoffzubereitungen aus umhüllten, schwerstwasserlöslichen Arzneistoffen für Inhalationsarzneiformen und Verfahren zu ihrer Herstellung
GB9322014D0 (en) 1993-10-26 1993-12-15 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
ATE233544T1 (de) * 1993-12-02 2003-03-15 Abbott Lab Aerosole als darreichungsform mit cfc-freiem treibmittel
GB9419536D0 (en) * 1994-09-28 1994-11-16 Glaxo Inc Medicaments
GB9501841D0 (en) 1995-01-31 1995-03-22 Co Ordinated Drug Dev Improvements in and relating to carrier particles for use in dry powder inhalers
GB9507768D0 (en) 1995-04-13 1995-05-31 Glaxo Group Ltd Method of apparatus
US5635161A (en) * 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9515182D0 (en) * 1995-07-24 1995-09-20 Co Ordinated Drug Dev Improvements in and relating to powders for use in dry powder inhalers
GB9526392D0 (en) 1995-12-22 1996-02-21 Glaxo Group Ltd Medicaments
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9612297D0 (en) * 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6193954B1 (en) 1997-03-21 2001-02-27 Abbott Laboratories Formulations for pulmonary delivery of dopamine agonists
US6120752A (en) * 1997-05-21 2000-09-19 3M Innovative Properties Company Medicinal aerosol products containing formulations of ciclesonide and related steroids
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6433040B1 (en) 1997-09-29 2002-08-13 Inhale Therapeutic Systems, Inc. Stabilized bioactive preparations and methods of use
US6309623B1 (en) 1997-09-29 2001-10-30 Inhale Therapeutic Systems, Inc. Stabilized preparations for use in metered dose inhalers
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
GB9805938D0 (en) 1998-03-19 1998-05-13 Glaxo Group Ltd Valve for aerosol container
US6264923B1 (en) 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
TW465235B (en) 1998-09-17 2001-11-21 United Video Properties Inc Electronic program guide with digital storage
DZ2947A1 (fr) 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317846B1 (it) 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
PT1280520E (pt) 2000-05-10 2014-12-16 Novartis Ag Pós à base de fosfolípidos para administração de fármacos
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
CN1213732C (zh) * 2000-05-22 2005-08-10 奇斯药制品公司 用于加压计量吸入器的稳定药用溶液制剂
US6451287B1 (en) 2000-05-26 2002-09-17 Smithkline Beecham Corporation Fluorinated copolymer surfactants and use thereof in aerosol compositions
GB0016876D0 (en) * 2000-07-11 2000-08-30 Astrazeneca Ab Novel formulation
AU2001290075A1 (en) 2000-09-22 2002-04-02 Glaxo Group Limited Novel alkanoic acid derivatives
KR100881258B1 (ko) 2000-12-22 2009-02-05 글락소 그룹 리미티드 살메테롤 지나포에이트를 위한 정량식 흡입기
US7905230B2 (en) 2001-05-09 2011-03-15 Novartis Ag Metered dose inhaler with lockout
ATE267591T1 (de) 2001-07-02 2004-06-15 Chiesi Farma Spa Optimierte tobramycin-formulierung zur aerosolbildung
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
DE60222591T2 (de) 2001-08-03 2008-06-19 Glaxo Group Ltd., Greenford Oberflächenaktive Verbindungen und ihre Anwendungen
GB0125127D0 (en) 2001-10-19 2001-12-12 Glaxo Group Ltd Compounds
GB0128148D0 (en) 2001-11-23 2002-01-16 Innovata Biomed Ltd Assembly
TWI324518B (en) 2001-12-19 2010-05-11 Nektar Therapeutics Pulmonary delivery of aminoglycosides
EP1474376A1 (en) 2002-02-13 2004-11-10 Glaxo Group Limited Carboxylic acid compounds for use as surfactants
GB0205327D0 (en) 2002-03-06 2002-04-17 Glaxo Group Ltd compounds
WO2004110460A1 (en) 2003-06-13 2004-12-23 Altana Pharma Ag Formoterol and ciclesonide combination
US8198354B2 (en) 2003-08-11 2012-06-12 Glaxo Group Limited Pharmaceutical metered dose inhaler and methods relating thereto
JP5053635B2 (ja) 2003-08-29 2012-10-17 グラクソ グループ リミテッド 医療用定量噴霧式吸入器及びそれに関連する方法
ES2452691T5 (es) 2003-09-16 2022-09-14 Covis Pharma Gmbh Uso de ciclesonida para el tratamiento de enfermedades respiratorias
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
WO2005102429A1 (en) 2004-04-21 2005-11-03 Innovata Biomed Limited Inhaler
AU2006287934B2 (en) 2005-05-18 2012-12-13 Nektar Therapeutics Valves, devices, and methods for endobronchial therapy
JP2009510077A (ja) 2005-09-29 2009-03-12 ネクター セラピューティックス 抗生物質製剤、単位用量、キットおよび方法
GB0614621D0 (en) 2006-07-24 2006-08-30 3M Innovative Properties Co Metered dose dispensers
GB0620700D0 (en) 2006-10-19 2006-11-29 3M Innovative Properties Co Metered dose valves and dispensers
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
DK2120875T3 (en) 2007-02-11 2018-10-22 Map Pharmaceuticals Inc METHOD OF THERAPEUTIC ADMINISTRATION OF DHE TO POSSIBLE QUICK PREVENTION OF MIGRANE AT THE MINIMUM OF THE SIDE EFFECT PROFILE
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2341942A1 (en) 2008-09-19 2011-07-13 Nektar Therapeutics Polymer conjugates of therapeutic peptides
JP2012514586A (ja) 2009-01-05 2012-06-28 フラウンホーファーゲゼルシャフト ツール フォルデルング デル アンゲヴァンテン フォルシユング エー．フアー． Ｉｌ−２１およびｉｌ−２１変異体に基づく抗体欠乏性疾患を治療するための手段および方法
AR079451A1 (es) 2009-12-18 2012-01-25 Nycomed Gmbh Compuestos 3,4,4a,10b-tetrahidro-1h-tiopirano[4,3-c]isoquinolina
WO2011150944A1 (en) 2010-06-04 2011-12-08 Trifoilium Aps Trefoil factors (tff) for the treatment of chronic pulmonary diseases
SG188401A1 (en) 2010-09-09 2013-04-30 Trifoilium Aps Airway administration of angiogenesis inhibitors
GB201108039D0 (en) 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
WO2012171903A1 (en) 2011-06-15 2012-12-20 Nycomed Gmbh Novel 3,4,4a,10b-tetrahydro-1h-thiopyrano[4,3-c]isoquinoline compounds
CA2837248A1 (en) 2011-06-17 2012-12-20 Takeda Gmbh Novel phthalazinone -pyrrolopyrimidinecarboxamide derivatives
GB201117619D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201117621D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201118188D0 (en) 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
GB201210580D0 (en) 2012-06-14 2012-08-01 3M Innovative Properties Co Metered dose dispensing valve
GB201221063D0 (en) 2012-11-23 2013-01-09 3M Innovative Properties Co Metered dose dispensing valve
GB201306984D0 (en) * 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
WO2016018892A1 (en) 2014-07-29 2016-02-04 3M Innovative Properties Company Method of preparing a pharmaceutical composition
ES2796177T3 (es) 2015-12-04 2020-11-26 Mexichem Fluor Sa De Cv Composición farmacéutica
CA3037080C (en) 2016-09-19 2021-05-18 Mexichem Fluor S.A. De C.V. Stable pharmaceutical compositions comprising indacaterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis)
UA123919C2 (uk) 2016-09-19 2021-06-23 Мехікем Флуор С.А. Де С.В. Фармацевтична композиція
CA3037107C (en) 2016-09-19 2021-05-18 Mexichem Fluor S.A. De C.V. Stable pharmaceutical compositions comprising salmeterol and 1,1-difluoroethane (hfa-152a) suitable for use in metered dose inhalers (mdis)
WO2018069210A1 (en) 2016-10-10 2018-04-19 Takeda Gmbh Tetrahydrofuro[3,4-c]isoquinolines as inhibitors of pde4

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3047640A (en) * 1960-03-22 1962-07-31 Allied Chem Production of fluoropropene
US3490923A (en) * 1966-07-28 1970-01-20 Du Pont Aerosol propellant composition used in dispensing foods
NL7708731A (nl) * 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US4352789A (en) * 1980-03-17 1982-10-05 Minnesota Mining And Manufacturing Company Aerosol compositions containing finely divided solid materials
WO1987003197A1 (en) * 1985-11-29 1987-06-04 Fisons Plc Pharmaceutical composition including sodium cromoglycate
US5248493A (en) * 1988-08-27 1993-09-28 Fisons Plc Pharmaceutical composition
US5225183A (en) * 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US4945119A (en) * 1989-05-10 1990-07-31 The Dow Chemical Company Foaming system for rigid urethane and isocyanurate foams
US5209921A (en) * 1989-05-19 1993-05-11 Beecham Group Plc Aerosol compositions
US5118494A (en) * 1990-03-23 1992-06-02 Minnesota Mining And Manufacturing Company Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
CA2086096A1 (en) 1990-06-27 1991-12-28 Robert A. Moris Use of soluble fluorosurfactants for the preparation of metered-dose aerosol formulations
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
US5173298A (en) * 1990-09-27 1992-12-22 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
US5290539A (en) * 1990-12-21 1994-03-01 Minnesota Mining And Manufacturing Company Device for delivering an aerosol
US5182097A (en) * 1991-02-14 1993-01-26 Virginia Commonwealth University Formulations for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5190029A (en) * 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
US5916540A (en) * 1994-10-24 1999-06-29 Glaxo Group Limited Aerosol formulations containing P134A and/or P227 and particulate medicament
CA2156408C (en) * 1993-03-17 2005-02-15 Daniel C. Duan Aerosol formulation containing a polyester dispersing aid

Also Published As

Publication number Publication date
NZ236948A (en) 1992-08-26
ES2075956T3 (es) 1995-10-16
JPH05503523A (ja) 1993-06-10
CA2074495C (en) 2003-12-16
CA2074495A1 (en) 1991-08-03
DE69111426D1 (de) 1995-08-24
WO1991011173A1 (en) 1991-08-08
GR3017611T3 (en) 1996-01-31
US6582677B1 (en) 2003-06-24
IL97065A (en) 1994-01-25
IL97065A0 (en) 1992-03-29
EP0513127B1 (en) 1995-07-19
PT96639B (pt) 1998-07-31
JP2858948B2 (ja) 1999-02-17
DK0513127T3 (da) 1995-10-30
ATE125153T1 (de) 1995-08-15
IE910289A1 (en) 1991-08-14
DE69111426T2 (de) 1996-01-18
EP0513127A1 (en) 1992-11-19
IE67185B1 (en) 1996-03-06

Similar Documents

Publication Publication Date Title
PT96639A (pt) Processo para a preparacao de uma composicao propulsora contendo hidro-fluoro-carbonetos
EP0384371B1 (de) Druckgaspackung und Treibmittel für Aerosole
CA2085884A1 (en) Pressurized hydrofluorocarbon aerosol compositions
CA2171303A1 (en) Active principles and gas containing microparticles
ES2089236T3 (es) Procedimiento de separacion de pentafluoroetano de una mezcla de hidrocarburos halogenados que contienen cloropentafluoroetano.
NZ239857A (en) Aqueous emulsion systems containing polyhydroxy alcohols, esters thereof or mixtures thereof and comprising vesicular structures
HUT68223A (en) Packagings under pressurized gas using polyoxyethylene glyceryl-obates and process for producing thereof
IL105944A (en) Phospholipid-containing cosmetic preparation and its production
ES2116818T3 (es) Dispositivo presurizado transparente con composicion espumante que comprende agentes tensioactivos no ionicos y anfoteros.
AU7120691A (en) Mixtures of dimethyl ether and of 1,1,1,2-tetrafluoroethane and their applications
CA2120361A1 (en) Substantially constant boiling compositions of difluoromethane and trifluoroethane of perfluoroethane
DK0427604T3 (da) Azetrop blanding
EP0383443A3 (en) Fire extinguishing compositions
JPS6456630A (en) Stabilization of hydrogen-containing flon
CA2150244A1 (en) Chlorofluoroether Compositions and Preparation Thereof
DE3065984D1 (en) Chlorinated hydrocarbons stabilized against decomposition by water, optionally mixed with ether, and fillings for aerosol containers prepared therefrom
TW374736B (en) Polyol-blowing agent compositions with improved storage stability
GB2020308A (en) Aerosol propellant
DE3065422D1 (en) 3-methyl-1,4-dioxa-bicyclo(4.4.0)decan-2-on, its preparation and use as perfume and perfume compositions containing it
DE3060778D1 (en) 4(5)-acetyl-9,9-dimethyltricyclo-(4,4,0,1(8,10))-undec-1-ene, its preparation and use as odorant, and odorant composition containing it
ES2012167A6 (es) Metodo de estabilizacion de fases laminares lipidicas hidratadas y composicion de fases laminares lipidicas hidratadas.

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910701

FG3A Patent granted, date of granting

Effective date: 19980403

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20130403